All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis | Zendy

JK Law | Zendy; B Salh | Zendy; E Yoshida | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis

Author(s) -

JK Law,

B Salh,

E Yoshida

Publication year - 2009

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2009/983121

Subject(s) - infliximab , ulcerative colitis , medicine , fulminant , refractory (planetary science) , gastroenterology , colitis , surgery , tumor necrosis factor alpha , disease , physics , astrobiology

The role of biological agents in moderate to severe ulcerative colitis has been shown to be effective in the induction of clinical remission. However, the role of infliximab therapy for induction of remission in patients with fulminant colitis is debatable. A case of a hospitalized patient with a new diagnosis of severe ulcerative colitis refractory to intravenous steroids is presented. The patient was treated with infliximab and discharged with clinical remission, but subsequently presented back to hospital with a lower gastrointestinal hemorrhage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research